Helix BioPharma Corp. Announces Fiscal Second Quarter 2019 Results

NEXT STORY
AzurRx BioPharma Announces Presentation on Its Positive Phase II Data in MS1819-SD in Chronic Pancreatitis at the 2019 Digestive Disease Week Conference
PREV STORY
Translate Bio Announces Publication of Preclinical Data Demonstrating Efficacy of Systemic mRNA Delivery in Fabry Disease Model in the Journal Molecular Therapy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2015 Earnings Call

SAN CLEMENTE, Calif., Jan. 22, 2016 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), a ...

author_avatar
NASDAQ Market News

Global Genome Editing Market (2020 to 2025) – By Technique, Applications, Source, End-user, Region, Forecast & Opportunities

author_avatar
NASDAQ Market News

ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19

author_avatar
NASDAQ Market News